Oncogenic Signaling Pathways Activated by RON Receptor Tyrosine Kinase

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|3|1|31-40

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.3, Iss.1, 2003-02, pp. : 31-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor

By  

Current Cancer Drug Targets, Vol. 13, Iss. 6, 2013-07 ,pp. : 686-697

Bentham Science Publishers

Access to resources Recommend Favorite

Signaling Pathways Modulating Dependence of Lung Cancer on Mutant Epidermal Growth Factor Receptor and Mechanisms of Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3883-3893

Bentham Science Publishers

Access to resources Recommend Favorite

Signal Transduction Pathways of G Protein-coupled Receptors and Their Cross-Talk with Receptor Tyrosine Kinases Lessons from Bradykinin Signaling

By  

Current Medicinal Chemistry, Vol. 7, Iss. 9, 2000-09 ,pp. : 911-943

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of the Fce Receptor I Signaling by Tyrosine Kinase Inhibitors: Search for Therapeutic Targets of Inflammatory and Allergy Diseases

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1727-1737

Bentham Science Publishers

Access to resources Recommend Favorite

Developing Target Therapy Against Oncogenic Tyrosine Kinase in Myeloid Maliganacies

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-10 ,pp. : 331-337

Bentham Science Publishers

Access to resources Recommend Favorite